glutathione pathway breast cancer Oncology Letters GSTP1 Is a Driver of
GSTP1 Is a Driver of Triple Negative Breast Cancer Cell Metabolism and Pathogenicity ScienceDirect Glutathione and Thioredoxin Antioxidant Pathways Synergize to Drive Cancer Initiation and Progression ScienceDirect reduced glutathione and breast cancer Glutathione responsive PROTAC for targeted degradation of ER in breast cancer Glutathione depletion and dihydroorotate dehydrogenase inhibition actuated ferroptosis augment to surmount triple negative breast cancer ScienceDirect
Pay in 4 interest-free payments of $5.66 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 19 - Sep 24



